Step 1: Understanding the Concept:
The question is looking for a drug that antagonizes the \( 5\text{-}HT_{2A/2C} \) serotonin receptors and is used in migraine, so the two things to check for each option are the receptor it acts on and whether it is an agonist or antagonist.
Step 2: Key Formula or Approach:
Separate the triptans, which are \( 5\text{-}HT_{1B/1D} \) agonists used for acute attacks, from the \( 5\text{-}HT_{2} \) antagonists, which act on a different receptor subtype for a different use case, migraine prophylaxis.
Step 3: Detailed Explanation:
Sumatriptan and rizatriptan both activate \( 5\text{-}HT_{1B/1D} \) receptors to stop an ongoing migraine attack, so neither one fits the antagonist role the question describes.
Ketanserin and methysergide both block \( 5\text{-}HT_{2} \) receptors, so the receptor target narrows the choice to these two.
Ketanserin's clinical use is as an antihypertensive agent, not for migraine, so it does not fit the indication in the question.
Methysergide blocks \( 5\text{-}HT_{2A} \) and \( 5\text{-}HT_{2C} \) receptors and is used to prevent migraine attacks by reducing serotonin-driven vasoconstriction and platelet aggregation, matching both the receptor and the indication.
Step 4: Final Answer:
Methysergide is the \( 5\text{-}HT_{2A/2C} \) antagonist used in migraine prophylaxis.